Contact Levi & Korsinsky by February 7, 2025 Deadline to Join Class Action Against Kyverna Therapeutics, Inc. (KYTX)
Portfolio Pulse from
A class action lawsuit has been filed against Kyverna Therapeutics, Inc. (NASDAQ:KYTX) for potential securities law violations. Investors who suffered losses are encouraged to join the lawsuit by February 7, 2025.
January 31, 2025 | 9:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Kyverna Therapeutics is facing a class action lawsuit for potential securities law violations. Investors who suffered losses are encouraged to join the lawsuit by February 7, 2025.
The announcement of a class action lawsuit against Kyverna Therapeutics is likely to negatively impact its stock price in the short term as it raises concerns about potential securities law violations and financial losses for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100